eResearch Technology Inc.
 (ERT)

- NASDAQ
ERT is defunct.
What's your position on ?
Bullish
Bearish
Why are you ish?
Skip
Post
You voted ish on Vote again
Posts appear on the My Feed page of subscribers to this ticker
Last vote:
  • Feb. 28, 2012, 11:40 AM

    eResearch Technology (ERT +16.9%) shares soar after Q4 results beat analyst estimates and Benchmark says it believes underlying clinical research industry trends recovered late in 2011 and have now returned to a favorable track. In raising shares to Buy, the firm expects improved margins, profitability and cash flow with the recent release of the Expert3 platform.

    | Feb. 28, 2012, 11:40 AM
  • Feb. 27, 2012, 6:27 PM

    More on eResearch Technology's (ERT) Q4: Bookings for the quarter were $82.5M, a new high and well above revenue of $52.3M. As a result, eResearch's total backlog grew 4% Q/Q to $357.4M. The company expects Q1 revenue of $46M-$49M and EPS of $0.08-$0.11 (consensus of $44.7M and $0.10), and 2012 revenue of $195M-$203M and EPS of $0.45-$0.53 (consensus of $195.2M and $0.46). ERT +15.7% AH. (PR)

    | Feb. 27, 2012, 6:27 PM
  • Feb. 27, 2012, 4:32 PM
    eResearch Technology (ERT): Q4 EPS of $0.14 beats by $0.06. Revenue of $52.3M (+8.7% Y/Y) beats by $5M. Shares +18.7% AH. (PR)
    | Feb. 27, 2012, 4:32 PM
  • Oct. 6, 2011, 3:49 PM
    eResearch Technology (ERT +4.6%) jumps after Citigroup upgraded the stock to buy from hold earlier today on valuation, saying the downward momentum in its business trend has bottomed.
    | Oct. 6, 2011, 3:49 PM
Company Description
Currently, there's no company description for ERT.